FDA Puts Clozapine REMS Requirements on Temporary Hold : vim

US regulators have put some of the new clozapine risk evaluation and mitigation strategy program on temporary hold because of start-up difficulties, including long telephone wait times.

Related Keywords

United States , American , , American Psychiatric Association , Drug Administration , Medscape Medical News , Schizophrenia , Us Food And Drug Administration , Nited States Food And Drug Administration , Fda , Schizoaffective Disorder , Antipsychotics , Neuroleptics , Neuroleptic Drugs , Patient Safety , Practice Management , Risk Evaluation And Mitigation Strategies Rems , Neutropenia , Pharmaceutical Services Insurance , Prescription Drug Coverage , Drug Coverage , Drug Benefit , Health Policy , Health Care Quality Access Ev ,